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Introduction. Castleman’s disease (CD) is a rare lymphoproliferative disorder. CD is divided into two clinical subtypes: the most
common unicentric and the less usual multicentric subtype. The majority of unicentric CD affects the mediastinum, while neck,
abdomen, and axilla are less common locations. Case Presentation. Herein, we describe a rare case of unicentric CD in the right
axilla in a 36-year-old white male with a medical history of hepatitis C virus infection admitted to our hospital due to palpation
of a painless mass in the right axilla. Complete excision of the lesion was performed and, one year after the diagnosis, patient was
free of the disease. Conclusions. Although infrequent, it is important to include CD in the differential diagnosis when evaluating
axillary lymphadenopathy particularly in young patients with a low-grade inflammation process and chronic disease even in the
absence of an abnormal blood picture or organomegaly.
1. Introduction
Castleman’s disease (CD) or angiofollicular lymph node
hyperplasia is a rare reactive lymphadenopathy of unknown
etiology. Possible pathogenetic factors include follicular den-
dritic cell dysplasia and immune dysregulation [1]. CD can
be divided into two clinical subtypes: the most common
unicentric (or localized) and the less common multicentric.
Localized disease is presented as lymphadenopathy and usu-
ally has a benign course [1]. On the other hand, multicentric
disease has aworse prognosis, leading to death bymalignancy
[1]. CD can also be classified into two major histological
variants: hyaline-vascular (HV-CD) and plasma cell variant
(PV-CD).TheHV-CD variant is more common than the PV-
CD [2]. Of the 315 reported cases of unicentric CD in a French
study, 65% were localized in the mediastinum, 16% in the
neck, 12% in the abdomen, 3% in the axilla, and 4% in diverse
locations [3]. Herein, we describe a rare case of unicentric CD
in the right axilla in a male patient.
2. Case Presentation
A 36-year-old white male was admitted to our hospital due to
palpation of a painless mass in the right axilla.The symptoms
had presented for approximately a week. His past medical
history included intravenous drug addiction (he had stopped
use one year prior to admission) and hepatitis C virus (HCV)
infection.
Clinical examination revealed the presence of an enlarged
lymph node group in the right axilla and multiple cat-
scratches in his upper extremities. No other palpable lymph
nodes were detected in the neck, the left axilla, and inguinal
regions. Palpation of the abdomen revealed no tenderness
or hepatosplenomegaly. Examination of his cardiovascular
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and respiratory system revealed no pathological signs. His
vital signs were blood pressure of 120/80mmHg, oxygen
saturation of 99%, temperature of 36.6∘C, and heart rate
of 72 bpm. The remaining laboratory exams were within
normal ranges. Computer tomography (CT) scans of the
chest and upper and lower abdomendid not reveal any patho-
logically enlarged lymph nodes or other abnormalities. The
initial differential diagnosis included (a) cat-scratch disease
(given the contact of the patient with the cat), (b) other
bacterial infections (staphylococcus and streptococcus), (c)
viral infections (Epstein-Barr virus, cytomegalovirus, and
human immunodeficiency virus (HIV)), and (d) neoplastic
lymphohyperplastic disorders/lymphomas. Serological tests
for Bartonella henselae (immunoglobulin G and M antibod-
ies) were negative. His viral serology was positive for HCV
while negative for HIV and herpesviruses. On the tenth
day of hospitalization, a right axillary lymphadenectomy
and a biopsy were performed. Histological examination
revealed preservation of nodes architecture in the majority
of tissue sample. Obliteration of subcapsular sinuses and
regressed germinal centers in typically large follicles, some of
which with “lollipop” features (onion skin appearance of the
mantle zone lymphocytes and sclerotic blood vessels radially
traversing into the germinal center), were detected (Figures
1–3). Small number of plasma cells and immunoblasts were
observed. These findings set the diagnosis of unicentric HV-
CD. Patient had an uneventful postoperative course and
he was dismissed a week later. One year after diagnosis,
a throughout clinical examination and a CT scan were
performed showing no evidence of remission of the disease.
3. Discussion
CD is a rare, benign condition that was first described
in 1956 in patients with single mediastinal lymph node
lymphadenopathy [1, 4]. The etiology and pathogenesis are
unknown but an immunoregulatory abnormality is impli-
cated in its development [1, 4]. An association of the multi-
centric type with human herpes virus- (HHV-) 8 infection
in HIV-positive patients has been documented and plays an
important role in the pathophysiology of the disease [5]. It
seems that CD is the result of a chronic low-grade inflamma-
tory process triggered by latent infection with HHV-8, which
leads to lymphoid system hyperplasia and also stimulates
secretion of interleukin-6 (IL-6) [6].
It has been suggested thatCD lymphnode abnormal over-
growth with or without systematic symptoms and organ dys-
function are probably caused by hypersecretion of cytokines.
A proposed key pathogenic factor for CD is the elevated levels
of circulating IL-6 [7].
Thus, of interest in this case, while the patient was
negative for HHV-8 and HIV infections, his serological tests
for HCV were found positive. Studies have documented the
elevated levels of IL-6 in HCV infection [8, 9].
However, to the best of our knowledge, there has been
no association between HCV infection and CD documented.
Extremely few case reports of coexistence of CD (especially
the multicentric type of disease) with HCV infection have
been published [10–13]. In our case, a potential relationship
Figure 1: Preserved lymph node architecture. Residual follicles with
atretic germinal centers.
Figure 2: H-E regressed germinal centers (black arrows) sur-
rounded by concentric layers of small lymphocytes (white arrows).
Two follicles with hyaline-vascular changes (yellow arrow).
Figure 3: Lymphocytes in the mantle zone are positive (black
arrows) for Bcl-2 and negative in the small regressed germinal center
(white arrows).
of HCV-induced elevated IL-6 levels and the development of
the CD cannot be supported while further investigations and
evidence are needed.
Unicentric CD is usually presented as mediastinal, hilar,
or intra-abdominal lymphadenopathy [1, 2]. Primary axillary
localization of HV-CD (as in our patient) accounts only for
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2-3% of the cases [14–17]. CD affects predominantly young
adult patients without gender predominance [2]. Patients are
presented with localized mass often detected accidentally or
with general symptoms such as fever, night sweats, andweight
loss. Symptoms related to compression of adjacent tissues are
rarely detected [2].
The most commonly described (77–91%) symptom of
unicentric CD is a mass (usually painless), like in our patient
[2]. Common laboratory anomalies include anemia, hypoal-
buminemia, polyclonal gammopathy, elevated erythrocyte
sedimentation rate or C-reactive protein concentration, and
proteinuria [18]. In the present case, patient’s laboratory
exams were normal. Diagnostic imaging methods such as
ultrasound and CT or magnet resonance imaging were not
specific. Hence, the gold standard for diagnosis is pathologi-
cal examination [19].
Treatment of choice for unicentric HV-CD is complete
resection, with excellent long-termprognosis (5-year survival
rate of nearly 100%) and uncommon relapse [1, 20]. However,
patients may develop malignant neoplasms, such as follicular
dendritic cell sarcomas or vascular neoplasms, associated
with HV-CD [20]. Radiotherapy has also been reported to be
effective in some patients with a variable response rate and
usually administered to alienate compressive symptoms [21].
4. Conclusions
In conclusion, primary axillary localization of CD is a rare
but possible cause of peripheral lymphadenopathy. Although
infrequent, it is important to include CD in the differential
diagnosis when evaluating axillary lymphadenopathy par-
ticularly in young patients with a low-grade inflammation
process and chronic disease even in the absence of an
abnormal blood picture or organomegaly.
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